Skip to main content
SpringerLink
Log in

Melanom: Hypophysitis durch Ipilimumab

  • Literatur kompakt
  • Published:
hautnah dermatologie Aims and scope

Auslöser einer Autoimmunhypophysitis können unter anderem immunmodulatorische Substanzen wie Ipilimumab sein. Symptomatik und Verlauf dieser Nebenwirkung wurden bei Melanompatienten untersucht.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Albarel F et al. Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma. Eur J Endorinol 2015; 172: 195–204

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Barbara Kreutzkamp

Authors
  1. Barbara Kreutzkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kreutzkamp, B. Melanom: Hypophysitis durch Ipilimumab. hautnah dermatologie 31, 23 (2015). https://doi.org/10.1007/s15012-015-1886-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15012-015-1886-9

Search

Navigation